KELBYSHEVA et al.
266
Yield of compound XIII in the solid-phase synthesis
by method a from 578 mg of D0-CHO and 509 mg of
(+)-pseudoephedrine 1.09 g (>98%).
b from 398 mg (0.3 mmol) of D1-CHO and 296 mg
(1.83 mmol) of (+)-pseudoephedrine in 50 ml of
chloroform. Yield 650 mg (99%), mp 108–109°C
(hexane–benzene), [α]D21 –14.0° (C 0.678, DMF).
1H NMR spectrum (CDCl3), δ, ppm: 1.20 d (18H, CH3,
J 6.3 Hz), 2.15 s (18H, NCH3), 2.48 m (6H, CHCH3),
4.75 d (6H, CHPh, J 8.3 Hz), 4.92 s (6H, NCHO), 5.01
s (12H, OCH2), 5.27 s (6H, COOCH2), 6.55 br.s (3H,
C6H3), 6.63 br.s (6H, C6H3), 7.20–7.43 m (30H, Ph and
12H, C6H4), 7.55 d (12H, C6H4, J 8 Hz), 8.90 s (3H,
C6H3). Mass spectrum, m/z: 2166 [M – H]+, 2060 [M –
PhCHOH]+, 2019 [M – C10H14N]+. Found, %: C 76.27;
H 6.39; N 3.97. C138H138N6O18. Calculated, %: C 76.42;
H 6.37; N 3.87.
1,3,5-Tris[(S,S)-4-(1-hydroxymethyl-2-methyl-
butyliminomethyl)benzyloxycarbonyl]benzene
(XIV) was obtained by method c from 1 g (1.8 mmol) of
D0-CHO and 0.67 g (5.7 mmol) of (+)-(2S,3S)-isoleucinol
in 25 ml of anhydrous ethanol in the presence of 3 g of
anhydrous Na2SO4. Yield 1.54 g (98%), mp 69–70°C
(hexane–benzene), [α]D21 24° (c 0.804, benzene). 1H
NMR spectrum of main isomer (CDCl3), δ, ppm: 0.86–
0.97 m (18H, CH3), 1.15 m (3H, CH2CH3), 1.26 m (3H,
CH2CH3), 1.72 m [3H, CH(Mε)Et], 2.93 m (3H, CHN),
3.94 m (3H, CH2OH), 4.1 m (3H, CH2OH), 5.42 s (6H,
CH2C6H4), 7.45 d and 7.78 d (12H, C6H4, J 7.7 Hz),
8.25 s (3H, CH=N), 8.88 s (3H, C6H3). Mass spectrum,
m/z: 863 [M + 2H]+, 763 [M + 2H – C6H12O]+. Found,
%: C 71.36; H 7.27; N 5.04. C51H63N3O9. Calculated,
%: C 71.05; H 7.37; N 4.87.
1,3,5-Tris(3,5-bis{4-[1-(S)-hydroxymethylpropyl-
imino]benzyloxy}benzyloxycarbonyl)benzene
(XVIII) was obtained by method c from 642 mg
(0.5 mmol) of D1-CHO and 267 mg (3 mmol) of (S)-2-
aminobutanol in 35 ml of anhydrous ethanol in the
presence of 5 g of anhydrous sodium sulfate. Yield 0.84 g
(98%), mp 142–143°C (hexane–benzene), [α]D21 2.4°
1,3,5-Tris[4-(S)-(1-hydroxymethylpropyl-
imino)benzyloxycarbonyl]benzene (XV) was obtained
by method b from 564 mg (1 mmol) of D0-CHO and
269 mg (3 mmol) of (+)-(S)-2-aminobutanol in 50 ml of
chloroform. Yield 767 mg (98%), mp 119–120°C
1
(C 0.829, DMF). H NMR spectrum of main isomer
(CDCl3), δ, ppm: 0.85 br.t (18H, CH3), 1.15 m (6H,
CH2Me), 1.40 m (6H, CH2Me), 1.73 m (6H, CHN), 3.8–
4.1 m (12H, CH2OH), 5.01 s (12H, OCH2), 5.30 s (6H,
COOCH2), 6.55 s (3H, C6H3), 6.68 m (6H, C6H3), 7.28–
7.63 m (12H, C6H4), 8.51 br.s (6H, CH=N), 9.0 s (3H,
C6H3). Mass spectrum, m/z: 1712 [M + H]+, 1640 [M –
C4H8O]+. Found, %: C 71.48; H 6.60; N 4.79.
C103H114N6O21× H2CO3. Calculated, %: C 71.56; H 6.71;
N 4.91.
(hexane–benzene), [α]D21 18° (C 0.752, DMF). H NMR
1
spectrum of main isomer (CDCl3), δ, ppm: 0.92 br.s (9H,
CH3), 1.28 m (6H, CH2CH3), 1.69 m (3H, CHN), 3.73 m
(6H, CH2OH), 5.48 s (6H, CH2), 7.51–7.81 m (12H,
C6H4), 8.45 s (3H, CH=N), 8.94 s (3H, C6H3). Mass
spectrum, m/z: 779 [M + 2H]+, 707 [M + 2H – C4H8O]+.
Found, %: C 69.36; H 6.67; N 5.41. C45H51N3O9.
Calculated, %: C 69.48; H 6.61; N 5.40.
1,3,5-Tris[4-(1R,2S)-(2-hydroxy-1-methyl-2-
phenylethylaminomethyl)benzyloxycarbonyl]benzene
(XIX). To a dispersion of 3 g of anhydrous sodium sulfate
in 25 ml of anhydrous EtOH was added 566 mg (1 mmol)
of D0-CHO and 456 mg (3 mmol) of (+)-norephedrine,
and the mixture was boiled for 2 h. Then the reaction
mixture was cooled to 0°C, and 40 mg (10 mmol) of
NaBH4 was added by portions, the mixture was
additionally stirred for 1 h and diluted with 100 ml of cold
water. The reaction products were extracted into AcOEt,
the extract was dried with Na2SO4. on filtering the solvent
was removed in a vacuum, the residue was crystallized
from a mixture hexane–benzene. Yield 941 mg (96%),
mp 70–72°C (hexane–benzene), [α]D21 –33° (C 0.880,
1,3,5-Tris{3,5-bis[4-(1R,2S)-(2-hydroxy-1-
methyl-2-phenylethylimino)benzyloxy]benzyl-
oxycarbonyl}benzene (XVI) was obtained by method
b from 797 mg (0.62 mmol) of D1-CHO and 562 mg
(3.72 mmol) of (+)-norephedrine in 50 ml of chloroform.
Yield 1.29 g (98%), mp 111–112°C (hexane–benzene),
[α]D21 2.0° (C 1.61, DMF). 1H NMR spectrum of imine
form (CDCl3), δ, ppm: 1.20 d (18H, CH3, J 7.6 Hz),
2.58 m (6H, CHCH3), 4.77 d (6H, CHOH, J 7.6 Hz),
5.00 s (12H, OCH2), 5.31 s (6H, COOCH2), 6.53 s (3H,
C6H3), 6.66 m (6H, C6H3), 7.23–7.32 m (30H, Ph), 7.36–
7.63 m (24H, C6H4), 8.17 s (6H, CH=N), 8.88 s (3H,
C6H3). Found, %: C 75.98; H 6.32; N 4.12.
C132H126N6O18. Calculated, %: C 76.05; H 6.10; N 4.03.
1
DMF). H NMR spectrum (CDCl3), δ, ppm: 1.09 d (9H,
CH3, J 6.2 Hz), 2.45 m (3H, CHCH3), 4.66 d (3H,
CHOH, J 7.9 Hz), 4.82 br.s (6H, CH2N), 5.35 s (6H,
CH2), 7.27–7.34 m (15H, Ph), 7.36 d (6H, C6H4,
1,3,5-Tris{3,5-bis[4-(4S,5S)-(3,4-dimethyl-5-
phenyl-1,3-oxazolidin-2-yl)benzyloxy]benzyl-
oxycarbonyl}benzene (XVII) was obtained by method
RUSSIAN JOURNAL OF ORGANIC CHEMISTRY Vol. 46 No. 2 2010